by Ben Mink | Apr 10, 2020 | VAWD/Quality
In February 2020, the National Association of Boards of Pharmacy (NABP) decided to rebrand it’s Verified Accredited Wholesale Distributor (VAWD) program. In doing so, the company eliminated the VAWD acronym and renamed the accreditation program to the...
by Ben Mink | Mar 9, 2020 | DEA Compliance
On February 11, 2020, two of GTC Consulting’s finest, Benjamin Mink and Eric Dufrene were awarded by the U.S. Attorney in the Eastern District of Louisiana. The recognition was given to them for their outstanding contributions in assisting the U.S....
by Ben Mink | Jan 23, 2020 | Company News
In December of 2019, GTC Consulting finalized plans to purchase 5 acres in the suburbs of Cincinnati, Ohio. This property will serve as the future headquarters for the company. According to the company’s President & CEO, “This investment is...
by Ben Mink | Jun 27, 2019 | Company News
On July 1, 2019, GTC Consulting will occupy a new office location in the city of Cincinnati. In reference to the new location, Benjamin Mink, who is the company’s President & CEO, stated the following: “2018 was a tremendous year for GTC Consulting and...
by Ben Mink | Jul 31, 2018 | VAWD/Quality
As a VAWD accreditation consultant, one of the questions I frequently get asked by prospects and clients is, why does it take so long to get the VAWD accreditation. In most cases, the prospect or client has made or is making one of five avoidable mistakes. By making...
by Ben Mink | Jun 11, 2018 | Company News
In the words of the late great, Steve Jobs, “Those who are crazy enough to think they can change the world usually do.” Well, we a GTC Consulting are that...
by Ben Mink | Apr 19, 2018 | DEA Compliance
What if I told you there was one question that if you asked your customers it today, it could potentially be the source of your salvation and drastically reduce your company’s overall risk profile? Would you implement it into you controlled substance questionnaires or...
by Ben Mink | Mar 29, 2018 | DEA Compliance
Arguably one of the most challenging responsibilities for those in the pharmaceutical supply chain handling controlled substances is the DEA’s “Know Your Customer” edict. It is a conundrum woven deep into the fabric of 21 CFR 1301.74. Many within the healthcare...
